Morningstar Investment Services LLC trimmed its stake in AmerisourceBergen Co. (NYSE:ABC – Get Rating) by 2.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 882,944 shares of the company’s stock after selling 21,457 shares during the period. AmerisourceBergen makes up about 2.0% of Morningstar Investment Services LLC’s investment portfolio, making the stock its 8th biggest position. Morningstar Investment Services LLC’s holdings in AmerisourceBergen were worth $144,070,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the stock. Principal Financial Group Inc. lifted its position in shares of AmerisourceBergen by 5.0% in the 4th quarter. Principal Financial Group Inc. now owns 281,056 shares of the company’s stock worth $46,574,000 after purchasing an additional 13,361 shares during the period. Canada Pension Plan Investment Board lifted its position in shares of AmerisourceBergen by 2.2% in the 3rd quarter. Canada Pension Plan Investment Board now owns 143,276 shares of the company’s stock worth $19,390,000 after purchasing an additional 3,100 shares during the period. Signaturefd LLC lifted its position in AmerisourceBergen by 7.8% during the fourth quarter. Signaturefd LLC now owns 2,082 shares of the company’s stock valued at $345,000 after acquiring an additional 150 shares during the last quarter. Peterson Financial Group Inc. purchased a new stake in AmerisourceBergen during the fourth quarter valued at approximately $285,000. Finally, Threadgill Financial LLC purchased a new stake in AmerisourceBergen during the fourth quarter valued at approximately $537,000. 84.79% of the stock is owned by hedge funds and other institutional investors.
AmerisourceBergen Price Performance
ABC stock traded down $1.01 during trading on Friday, hitting $169.16. The company had a trading volume of 341,265 shares, compared to its average volume of 1,248,524. The firm has a market capitalization of $34.25 billion, a price-to-earnings ratio of 21.87, a P/E/G ratio of 1.63 and a beta of 0.52. The business has a 50 day moving average of $165.66 and a 200 day moving average of $163.19. AmerisourceBergen Co. has a fifty-two week low of $135.14 and a fifty-two week high of $176.62. The company has a current ratio of 0.89, a quick ratio of 0.51 and a debt-to-equity ratio of 9.13.
AmerisourceBergen Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 30th. Stockholders of record on Friday, May 12th will be issued a dividend of $0.485 per share. The ex-dividend date is Thursday, May 11th. This represents a $1.94 dividend on an annualized basis and a dividend yield of 1.15%. AmerisourceBergen’s dividend payout ratio (DPR) is presently 24.94%.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on ABC. Robert W. Baird upped their price target on shares of AmerisourceBergen from $199.00 to $201.00 and gave the company an “outperform” rating in a research note on Thursday, February 2nd. Barclays raised their price target on shares of AmerisourceBergen from $182.00 to $189.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 3rd. Evercore ISI restated an “outperform” rating and set a $185.00 price objective on shares of AmerisourceBergen in a research report on Tuesday, January 31st. StockNews.com started coverage on shares of AmerisourceBergen in a research report on Thursday, May 18th. They set a “strong-buy” rating for the company. Finally, TheStreet upgraded shares of AmerisourceBergen from a “c” rating to a “b+” rating in a research report on Tuesday, May 2nd. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, AmerisourceBergen currently has a consensus rating of “Moderate Buy” and an average price target of $181.62.
Insider Transactions at AmerisourceBergen
In related news, EVP Gina Clark sold 1,924 shares of the company’s stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $156.22, for a total value of $300,567.28. Following the completion of the transaction, the executive vice president now directly owns 26,733 shares in the company, valued at $4,176,229.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Gina Clark sold 1,924 shares of the company’s stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $156.22, for a total value of $300,567.28. Following the completion of the transaction, the executive vice president now directly owns 26,733 shares in the company, valued at $4,176,229.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Walgreens Boots Alliance, Inc. sold 292,792 shares of the stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $170.77, for a total value of $50,000,089.84. Following the transaction, the insider now owns 33,366,388 shares of the company’s stock, valued at $5,697,978,078.76. The disclosure for this sale can be found here. Insiders sold a total of 326,213 shares of company stock worth $55,412,200 over the last three months. 20.10% of the stock is currently owned by insiders.
AmerisourceBergen Company Profile
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies.
- Get a free copy of the StockNews.com research report on AmerisourceBergen (ABC)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Co. (NYSE:ABC – Get Rating).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.